Latest news

Barclays analyst Christine Cho initiates coverage on Enphase Energy (NASDAQ:ENPH) with a Equal-Weight rating and announces Price Target of $292.

Someone with a lot of money to spend has taken a bearish stance on Enphase Energy (NASDAQ:ENPH). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Beware of Deceptive Stats Sometimes, you've got to look beyond the rosy headline stats to get a clearer picture of what's happening pseudonymous macro account "MrBlonde" did just that in this Twitter thread on Sunday, showing that corporate earnings in the 2nd Quarter are actually worse than they look. 

Enphase Energy (NASDAQ:ENPH) has outperformed the market over the past 5 years by 201.14% on an annualized basis producing an average annual return of 211.8%. Currently, Enphase Energy has a market capitalization of $38.32 billion.

Credit Suisse analyst Maheep Mandloi upgrades Enphase Energy (NASDAQ:ENPH) from Neutral to Outperform and raises the price target from $174 to $281.

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.

 

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.

A whale with a lot of money to spend has taken a noticeably bearish stance on Enphase Energy. Looking at options history for Enphase Energy (NASDAQ:ENPH) we detected 30 strange trades.